Sector consensus Telix Pharmaceuticals Limited
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.26 AUD | +2.77% |
|
+4.86% | +2.64% |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
$31.93 | +26.41% | 9 | |||||||
CHF 665.59 | +16.81% | 22 | |||||||
USD 335.45 | +13.89% | 23 | |||||||
KRW 215,992.16 | +19.8% | 22 | |||||||
USD 190.67 | +18.7% | 20 | |||||||
EUR 60.4 | -1.56% | 13 | |||||||
USD 176 | +22.61% | 15 | |||||||
USD 66.77 | +9.5% | 11 | |||||||
USD 50.57 | +4.57% | 14 | |||||||
USD 201.39 | +38.15% | 16 | |||||||
USD 301.61 | -3.29% | 12 | |||||||
USD 130.71 | +0.97% | 14 | |||||||
USD 66.05 | +26.96% | 14 | |||||||
USD 160.55 | +3.93% | 17 | |||||||
USD 72.25 | +88.64% | 12 | |||||||
CNY 56.55 | -3.37% | 13 | |||||||
USD 58.3 | +39.61% | 27 | |||||||
CNY 30.22 | +14.97% | 11 | |||||||
Average | 12,147.07 | +18.74% | 16 | ||||||
Weighted average by Cap. | 23,826.91 | +17.28% | 18 |
- Stock Market
- Equities
- TLX Stock
- Sector Telix Pharmaceuticals Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition